Advanced Cardiovascular Screening with the Cleerly Test and Advanced Biomarkers
Revolutionizing Heart Health Through Precision Diagnostics
What is the Cleerly Test?
The Cleerly Test is a cutting-edge, non-invasive imaging solution that uses artificial intelligence (AI) to analyze the structure and function of coronary arteries. Unlike traditional screening methods, which focus primarily on indirect risk factors like cholesterol, the Cleerly Test directly visualizes and quantifies atherosclerosis (plaque buildup) in the arteries, identifying early signs of coronary artery disease (CAD) before symptoms arise. For more information about Cleerly Health and their innovative approach to cardiovascular screening, visit the official website: Cleerly Health - Individuals.
Why Combine the Cleerly Test with Advanced Biomarkers?
By integrating the Cleerly Test with Advanced Biomarkers, we provide a comprehensive assessment of your heart health. The Cleerly Test offers a detailed look at arterial plaque, while advanced biomarkers analyze biochemical and genetic factors contributing to cardiovascular disease. Together, these methods offer a complete view of your cardiovascular risk.
The Key Components of This Advanced Screening
1. Cleerly Test – AI-Powered Coronary Artery Analysis
The Cleerly Test offers:
- Precise plaque quantification: distinguishes between dangerous types of plaque, such as calcified and non-calcified (soft) plaque.
- Coronary artery visualization: advanced imaging to assess blockages and overall arterial health.
- AI-driven analysis: machine learning algorithms provide comprehensive data on coronary health.
- Personalized heart health reports: easy-to-understand reports based on real-time arterial health data.
2. Advanced Biomarker Analysis
Advanced biomarkers give deeper insights into cardiovascular risk, beyond traditional tests:
- Lipoprotein(a) [Lp(a)]: genetic factor linked to atherosclerosis and cardiovascular events.
- High-Sensitivity C-Reactive Protein (hs-CRP): measures inflammation linked to cardiovascular disease.
- Oxidized LDL (oxLDL): assesses oxidized cholesterol particles that contribute to plaque formation.
- Fibrinogen: elevated levels indicate a higher risk of blood clots.
- Homocysteine: high levels can damage artery linings, increasing cardiovascular risk.
- Apolipoprotein B (ApoB): tracks the number of harmful particles linked to heart disease.
- Endothelial function markers: measure vascular health and early signs of arterial dysfunction.
- Apo E Apolipoprotein E (ApoE) is a protein involved in the metabolism of fats (lipids) in the body, playing a key role in transporting and redistributing cholesterol and other lipids.
Benefits of Comprehensive Cardiovascular Screening
1. Early Detection of Cardiovascular Risk
Combining the Cleerly Test and advanced biomarkers identifies cardiovascular risks early, providing the opportunity for effective intervention before symptoms arise. Here is a real life example and explanation of the test. Cleerly Example and Explanation - Real Life Case
2. Personalized Treatment Plans
Results from these tests enable us to develop personalized cardiovascular prevention and treatment plans, addressing diet, lifestyle, and potential medications tailored to your risk profile.
3. Better Risk Stratification
Advanced screening methods offer more precise risk stratification than traditional cholesterol and blood pressure tests, leading to targeted prevention.
4. Enhanced Monitoring and Long-Term Care
Regular monitoring with the Cleerly Test and biomarkers ensures any changes in plaque or biomarkers are detected early, allowing for timely treatment adjustments.
Who Should Consider This Screening?
The Cleerly Test and Advanced Biomarker screening is ideal for:
- Individuals with a family history of heart disease or stroke.
- Patients with high cholesterol, high blood pressure, or diabetes.
- People experiencing symptoms like chest pain or shortness of breath.
- Athletes or those seeking to optimize their heart health.
- Anyone wanting a thorough assessment of cardiovascular risk.
What to Expect from the Screening Process
The screening process includes:
- Initial Consultation: Discuss your health history and goals with a healthcare provider.
- Cleerly Test Imaging: A non-invasive coronary artery scan, typically taking 10–20 minutes.
- Blood Sample Collection: A blood sample is taken for advanced biomarker analysis.
- Results Review: Your provider will explain the Cleerly Test and biomarker results in detail.
- Personalized Action Plan: Based on your results, a tailored prevention or treatment plan will be created.
Take Control of Your Cardiovascular Health Today
The Cleerly Test and advanced biomarker screening offer unparalleled insights into your heart health. Early detection and personalized care plans empower you to take control of your cardiovascular wellness.
Schedule your Advanced Cardiovascular Screening today and take the first step toward a healthier heart.
Contact Us
To learn more or schedule your screening, call 858-254-5433 or email [email protected].
